STOCKSERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINEUpdated 2026-04-19
Here’s whether Teladoc Health, Inc. (TDOC) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bearish.
🔴
Bearish
Positives: above the 50-day MA (medium-term momentum positive). Concerns: trading below the 200-day MA (long-term downtrend); 50-day MA is falling (-1.29% over 10 days); weak 1-year return of -17.5%; 3-month momentum negative (-9.4%). Currently 41.8% off its 52-week high. Score: -4/7.
TDOC is trading below its 200-day MA ($6.99) — a key warning sign the longer-term trend is under pressure. An RSI of 67.1 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -17.5% compares to +35.1% for SPY (trailed the market by 52.6%). The current 41.8% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.
$10,000 invested 1 year ago→ $8,246 today
vs. S&P 500 (SPY) — same period trailed market by 52.6%